Table 5

Patient characteristics per subgroup

Patient characteristics.


requested SO group

Control group

p


Included patients

188 (100%)

178 (100%)


Sex

Males

102 (54.3%)

82 (46.1%)

0.117

Females

86 (45.7%)

96 (53.9%)


Age (years)

Mean

57.9

59.6

Median

62

61

0.359

Range

[15-86]

[18-92]


Types of tumor

Soft tissue

117 (62.2%)

98 (55.1%)

Bone tissue

13 (6.9%)

8 (4.5%)

0.128

Visceral tissue

58 (30.9%)

72 (40.4%)


Localization

Upper limb

15 (8.%)

19 (10.7%)

Lower limb

45 (23.9%)

31 (17.4%)

Abdomen

44 (23.4%)

57 (32%)

Thorax

31 (16.5%)

23 (12.9%)

0.313

Head and Neck

16 (8.5%)

13 (7.3%)

Pelvis

25 (13.3%)

20 (11.2%)

Retroperitoneum

10 (5.3%)

11 (6.2%)

Axial skeleton

1 (0.5%)

0 (0%)

Multiple localizations

1 (0.5%)

4 (2.2%)


Grade

Grade I

47 (25%)

38 (21.3%)

Grade II

36 (19.1%)

41 (23%)

Grade III

50 (26.6%)

47 (26.4%)

0.716

Non applicable

52 (27.2%)

51 (28.7%)

Unknown

3 (1.6%)

1 (0.6%)


Histological subtypes

Liposarcoma

37 (19.7%)

19 (10.7%)

NOS Sarcoma

32 (17.0%)

20 (11.2%)

GIST

23 (12.2%)

42 (23.6%)

Myxofibrosarcoma

9 (4.8%)

3 (1.7%)

Leiomyosarcoma

7 (3.7%)

19 (10.7%)

PNET/Ewing

6 (3.2%)

2 (1.1%)

Rhabdomyosarcoma

6 (3.2%)

2 (1.1%)

< 0.001.

Chondrosarcoma

6 (3.2%)

3 (1.7%)

Dermatofibrosarcoma

4 (2.1%)

16 (9.0%)

protuberans

Uterine Leiomyosarcoma

5 (2.7%)

7 (3.9%)

Osteosarcoma

5 (2.7%)

6 (3.4%)

Kaposi Sarcoma

5 (2.7%)

13 (7.3%)

Synovialosarcoma

5 (2.7%)

2 (1.1%)

Angiosarcoma

3 (1.6%)

7 (3.9%)

Unclassified malignant tumor

7 (3.7%)

7 (3.9%)

Other

28 (14.9%)

10 (5.6%)


Lurkin et al. BMC Cancer 2010 10:150   doi:10.1186/1471-2407-10-150

Open Data